Development of a luminescence syncytium induction assay (LuSIA) for easily detecting and quantitatively measuring bovine leukemia virus infection
暂无分享,去创建一个
Y. Aida | Hironobu Murakami | Reiichiro Sato | H. Ishizaki | Sonoko Watanuki | Hirotaka Sato | S. Watanuki
[1] Y. Aida,et al. Risk factors associated with increased bovine leukemia virus proviral load in infected cattle in Japan from 2012 to 2014. , 2015, Virus research.
[2] Y. Aida,et al. Detection of the BLV provirus from nasal secretion and saliva samples using BLV-CoCoMo-qPCR-2: Comparison with blood samples from the same cattle. , 2015, Virus research.
[3] Y. Aida,et al. Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle , 2015, Retrovirology.
[4] Yuan Yuan,et al. BLV-CoCoMo-qPCR-2: improvements to the BLV-CoCoMo-qPCR assay for bovine leukemia virus by reducing primer degeneracy and constructing an optimal standard curve , 2015, Archives of Virology.
[5] Y. Aida,et al. Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus , 2013, Front. Microbiol..
[6] T. Nunoya,et al. Estimation of bovine leukemia virus (BLV) proviral load harbored by lymphocyte subpopulations in BLV-infected cattle at the subclinical stage of enzootic bovine leucosis using BLV-CoCoMo-qPCR , 2013, BMC Veterinary Research.
[7] R. Erskine,et al. Association between bovine leukemia virus, production, and population age in Michigan dairy herds. , 2012, Journal of dairy science.
[8] Y. Aida,et al. Identification of bovine leukemia virus tax function associated with host cell transcription, signaling, stress response and immune response pathway by microarray-based gene expression analysis , 2012, BMC Genomics.
[9] Y. Aida,et al. BLV-CoCoMo-qPCR: Quantitation of bovine leukemia virus proviral load using the CoCoMo algorithm , 2010 .
[10] David C Montefiori,et al. Measuring HIV neutralization in a luciferase reporter gene assay. , 2009, Methods in molecular biology.
[11] N. Jewell,et al. Construction and characterization of deltaretrovirus indicator cell lines. , 2005, Journal of virological methods.
[12] A. Burny,et al. Overlapping CRE and E Box Motifs in the Enhancer Sequences of the Bovine Leukemia Virus 5′ Long Terminal Repeat Are Critical for Basal and Acetylation-Dependent Transcriptional Activity of the Viral Promoter: Implications for Viral Latency , 2004, Journal of Virology.
[13] A. Söling,et al. Genetic Vaccines and Therapy , 2004 .
[14] A. Burny,et al. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat , 2003, Oncogene.
[15] S. Tajima,et al. Latency of Viral Expression In Vivo Is Not Related to CpG Methylation in the U3 Region and Part of the R Region of the Long Terminal Repeat of Bovine Leukemia Virus , 2003, Journal of Virology.
[16] S. Tajima,et al. The Influence of Ovine MHC Class II DRB1 Alleles on Immune Response in Bovine Leukemia Virus Infection , 2003, Microbiology and immunology.
[17] Mitsuhiro Osame,et al. Spread of HTLV-I Between Lymphocytes by Virus-Induced Polarization of the Cytoskeleton , 2003, Science.
[18] Yoshimasa Tanaka,et al. A Mutant Form of the Tax Protein of Bovine Leukemia Virus (BLV), with Enhanced Transactivation Activity, Increases Expression and Propagation of BLV In Vitro but Not In Vivo , 2003, Journal of Virology.
[19] S. Tajima,et al. Mutant Tax Protein from Bovine Leukemia Virus with Enhanced Ability To Activate the Expression of c-fos , 2002, Journal of Virology.
[20] S. Oka,et al. Rapid and Simple Phenotypic Assay for Drug Susceptibility of Human Immunodeficiency Virus Type 1 Using CCR5-Expressing HeLa/CD4+ Cell Clone 1-10 (MAGIC-5) , 2001, Antimicrobial Agents and Chemotherapy.
[21] S. Tajima,et al. The Region between Amino Acids 245 and 265 of the Bovine Leukemia Virus (BLV) Tax Protein Restricts Transactivation Not Only via the BLV Enhancer but Also via Other Retrovirus Enhancers , 2000, Journal of Virology.
[22] J. Goyache,et al. In vitro infection of cells of the monocytic/macrophage lineage with bovine leukaemia virus. , 2000, The Journal of general virology.
[23] 長岡 淑子. Ovine MHC class II DRB1 alleles associated with resistance or susceptibility to development of bovine leukemia virus-induced ovine lymphoma , 1999 .
[24] G. Buehring,et al. In Vivo Protein Binding and Functional Analysis ofcis-Acting Elements in the U3 Region of the Bovine Leukemia Virus Long Terminal Repeat , 1998, Journal of Virology.
[25] V. Kiermer,et al. An Interferon Regulatory Factor Binding Site in the U5 Region of the Bovine Leukemia Virus Long Terminal Repeat Stimulates Tax-Independent Gene Expression , 1998, Journal of Virology.
[26] K. Ikuta,et al. Transmission and propagation in cell culture of virus produced by cells transfected with an infectious molecular clone of bovine leukemia virus. , 1998, Virology.
[27] Y. Aida,et al. B-1a, B-1b and conventional B cell lymphoma from enzootic bovine leukosis. , 1996, Veterinary immunology and immunopathology.
[28] K Frech,et al. Common modular structure of lentivirus LTRs. , 1996, Virology.
[29] M. Powers,et al. Peripheral blood mononuclear cells from sheep infected with a variant of bovine leukemia virus synthesize envelope glycoproteins but fail to induce syncytia in culture , 1996, Journal of virology.
[30] H. Lewin,et al. The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection , 1996, Journal of virology.
[31] S Falkow,et al. FACS-optimized mutants of the green fluorescent protein (GFP). , 1996, Gene.
[32] B. Polack,et al. In vivo leukocyte tropism of bovine leukemia virus in sheep and cattle , 1994, Journal of virology.
[33] E. Paoletti,et al. Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Emerman,et al. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene , 1992, Journal of virology.
[35] A. Miller,et al. Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor , 1992, Journal of virology.
[36] M. Thurmond,et al. Integrated bovine leukosis proviral DNA in T helper and T cytotoxic/suppressor lymphocytes. , 1991, The Journal of general virology.
[37] Williams Dl,et al. Enumeration of T and B lymphocytes in bovine leukemia virus-infected cattle, using monoclonal antibodies. , 1988 .
[38] W. Davis,et al. Enumeration of T and B lymphocytes in bovine leukemia virus-infected cattle, using monoclonal antibodies. , 1988, American journal of veterinary research.
[39] D. Derse. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements , 1987, Journal of virology.
[40] M. Miyasaka,et al. Sheep as an Experimental Model for Immunology: Immunological Techniques in Vitro and in Vivo , 1985 .
[41] T. Yasunaga,et al. Bovine leukemia virus: unique structural features of its long terminal repeats and its evolutionary relationship to human T-cell leukemia virus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[42] D. Graves,et al. Early Syncytium Formation by Bovine Leukemia Virus , 1981, Journal of virology.
[43] P. Gupta,et al. Use of a feline cell line in the syncytia infectivity assay for the detection of bovine leukemia virus infection in cattle. , 1981, American journal of veterinary research.
[44] L. Jerabek,et al. An infectivity assay for the bovine leukemia virus based on the induction of the major internal virion antigen in susceptible cell cultures. , 1978, Annales de recherches veterinaires. Annals of veterinary research.
[45] D. Graves,et al. In vitro transmission and propagation of the bovine leukemia virus in monolayer cell cultures. , 1976, Cancer research.